Article
NTG-102: A Refined Molecular Therapeutic to Treat Degenerative Disc Disease
2026-03-10
Abstract excerpt
<title>Abstract</title> <p> Background Degenerative Disc Disease (DDD) is characterized by the death of IVD cells, degradation of healthy extra-cellular matrix proteins, the overexpression of pro-inflammatory cytokines and matrix degradation enzymes as well as structural compromise of the IVD. A successful biological therapy needs to induce repair and promote cell viability as well as confer anti-inflammatory /...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 4edd3cbd-c30d-596c-bc52-efc5591e1c3c
- DOI
- 10.21203/rs.3.rs-8419595/v1
